Bone Solutions received FDA 510(k) clearance to market Mg OSTEOCRETE for use in the intervertebral body disc space, including cervical, thoracic and lumbar fusion procedures. This marks the first and only magnesium-based bone substitute to be cleared by FDA for this application.
Mg OSTEOCRETE is a fast-setting bone substitute that remodels into bone over time through creeping substitution. This remodeling profile means that the material provides needed support to the defect or void during the healing process, then transforms into bone at an optimal rate. The product is already cleared for use in posterolateral spine procedures.
The magnesium component of Mg OSTEOCRETE is the significant differentiator from other bone substitutes on the market. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for ideal osteoconductivity of the product. As a result, post-placement Mg OSTEOCRETE sets and cures in situ without migration. The material stimulates cell adhesion, proliferation and formation of the bone extracellular matrix by the osteoblasts, promoting bone growth.
Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it is filling. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque.
Mg OSTEOCRETE is distributed nationwide to facilities and surgical centers for immediate clinical use.
Bone Solutions received FDA 510(k) clearance to market Mg OSTEOCRETE for use in the intervertebral body disc space, including cervical, thoracic and lumbar fusion procedures. This marks the first and only magnesium-based bone substitute to be cleared by FDA for this application.
Bone Solutions received FDA 510(k) clearance to market Mg OSTEOCRETE for use in the intervertebral body disc space, including cervical, thoracic and lumbar fusion procedures. This marks the first and only magnesium-based bone substitute to be cleared by FDA for this application.
Mg OSTEOCRETE is a fast-setting bone substitute that remodels into bone over time through creeping substitution. This remodeling profile means that the material provides needed support to the defect or void during the healing process, then transforms into bone at an optimal rate. The product is already cleared for use in posterolateral spine procedures.
The magnesium component of Mg OSTEOCRETE is the significant differentiator from other bone substitutes on the market. The crystallization reaction from magnesium oxide and the blend of phosphate-based materials allows for ideal osteoconductivity of the product. As a result, post-placement Mg OSTEOCRETE sets and cures in situ without migration. The material stimulates cell adhesion, proliferation and formation of the bone extracellular matrix by the osteoblasts, promoting bone growth.
Ready for use after only 30 seconds of mixing, the material is moldable or injectable and is cohesive and adhesive to the area it is filling. Once implanted, the material sets quickly, is drillable after only two minutes, and is also radiopaque.
Mg OSTEOCRETE is distributed nationwide to facilities and surgical centers for immediate clinical use.
Copy to clipboard 
